UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 5.

Brandes, A A; Franceschi, E; Gorlia, T; Wick, W; Jacobs, A H; Baumert, B G; van den Bent, M; Weller, M; Stupp, R (2012). Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma. European Journal of Cancer, 48(6):896-903.

Guggenheim, M; Giovanoli, P; Baumert, B G; Eigentler, T K; Garbe, C; Mangana, J; Dummer, R (2011). Melanoma. In: Dummer, R; Pittelkow, M; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 307-341.

Baumert, B G; Spahr, M O; von Hochstetter, A; Beauvois, S K; Landmann, C; Fridrich, K S; VillĂ , S; Kirschner, M J; Storme, G; Thum, P; Streuli, H K; Lombriser, N; Maurer, R; Ries, G; Bleher, E A; Willi, A; Allemann, J; Buehler, U; Blessing, H; Luetolf, U M; Davis, J B; Seifert, Burkhardt; Infanger, M (2007). The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiation Oncology, 2:12.

Baumann, F; Bjeljac, M; Kollias, S S; Baumert, B G; Brandner, S; Rousson, V; Yonekawa, Y; Bernays, R L (2004). Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme. Journal of Neuro-Oncology, 67(1-2):191-200.

Meier, S; Baumert, B G; Maier, T; Wellis, G; Burg, G; Seifert, Burkhardt; Dummer, R (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2):145-149.

This list was generated on Sun Jul 23 07:29:54 2017 CEST.